Abstract

An increasing number of Nuclear Medicine sites in Europe are using cardiac-centered gamma cameras for myocardial perfusion scintigraphy (MPS). Three cardiac-centered gamma cameras are currently the most frequently used in Europe: the D-SPECT (Spectrum Dynamics), the Alcyone (Discovery NM 530c and Discovery NM/CT 570c; General Electric Medical Systems), and the IQ-SPECT (Siemens Healthcare). The increased myocardial count sensitivity of these three cardiac-centered systems has allowed for a decrease in the activities of radiopharmaceuticals injected to patients for myocardial perfusion imaging and, consequently, radiation exposure of patients. When setting up protocols for MPS, the overall objective should be to maintain high diagnostic accuracy of MPS, while injecting the lowest activities reasonably achievable to reduce the level of radiation exposure of patient and staff. These guidelines aim at providing recommendations for acquisition protocols and image interpretation using cardiac-centered cameras. As each imaging system has specific design and features for image acquisition and analysis, these guidelines have been separated into three sections for each gamma camera system. These recommendations have been written by the members of the Cardiovascular Committee of EANM and were based on their own experience with each of these systems and on the existing literature.

Highlights

  • Introduction and technical overviewA growing number of nuclear medicine sites in Europe are using a new generation of cardiac-centered gamma cameras for myocardial perfusion imaging

  • On Anger cameras, this fraction may be increased when using a collimator with convergent geometry such as the SMARTZOOM multifocal collimator system for IQ-SPECT focused on the heart

  • Using a CZT camera equipped with heart-centric collimators, the tomographic count sensitivity is increased up to three- to fourfold with the Discovery NM530c camera and seven- to eightfold with the D-SPECT camera in comparison to conventional Anger cameras (Imbert et al 2012)

Read more

Summary

Open Access

Fabien Hyafil1* , Alessia Gimelli, Riemer H. Verberne on behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

Injected activities
Estimated total
Image acquisition
Findings
Clinical validation
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call